Expertise in
23
conditions

Dr. Andrew P. Dalovisio

Hematology
Hematology Oncology Associates Of Baton Rouge
4950 Essen Ln, 
Baton Rouge, LA 
Accepting New Patients
Offers Telehealth
17 Years of Experience
Expertise in
23
conditions
Hematology Oncology Associates Of Baton Rouge
4950 Essen Ln, 
Baton Rouge, LA 

Overview

Andrew Dalovisio is a Hematologist practicing medicine in Baton Rouge, Louisiana. He has been practicing medicine for over 17 years.

Dr. Dalovisio is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 5 clinical trials. Dr. Dalovisio is currently accepting new patients.

Graduate Year

2009

Specialties

Hematology

Licenses

Internal Medicine in IL

Hospital Affiliations

Ochsner Medical Center Acute
Baton Rouge General Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Hematology Oncology Associates of Baton Rouge
4950 Essen Ln, Baton Rouge, LA 70809
Other Locations
Ochsner Clinic Foundation
1514 Jefferson Hwy, New Orleans, LA 70121

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Drug, Procedure, Biological
Study Drugs: Blinatumomab, Cyclophosphamide, Cytarabine, Daunorubicin, Daunorubicin Hydrochloride, Dexamethasone, Etoposide, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone, Rituximab, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Other, Procedure
Study Drugs: Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Melphalan
Study Phase: Phase 3
Phase 2, Randomized, Biomarker-driven Clinical Study in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With MCL-1 Dependence ≥30%
Phase 2, Randomized, Biomarker-driven Clinical Study in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With MCL-1 Dependence ≥30%
Enrollment Status: Terminated
Publish Date: November 15, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Open-label, Randomized, Two-stage Clinical Study of Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia Following Treatment With Venetoclax Combination Therapy
A Phase 2, Open-label, Randomized, Two-stage Clinical Study of Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia Following Treatment With Venetoclax Combination Therapy
Enrollment Status: Terminated
Publish Date: November 09, 2023
Intervention Type: Drug
Study Drugs: Alvocidib, Cytarabine
Study Phase: Phase 2
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
Enrollment Status: No_longer_available
Publish Date: July 15, 2020
Intervention Type: Drug
View 4 Less Clinical Trials

6 Total Publications

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
Journal: Nature medicine
Published: May 10, 2023
Similar Doctors
Expertise in
55
conditions
Dr. Siva Sankar-Yadlapati
Hematology | Oncology
Expertise in
55
conditions
Dr. Siva Sankar-Yadlapati
Hematology | Oncology
Referral may be required

Hematology Oncology Associates Of Baton Rouge

4950 Essen Ln, 
Baton Rouge, LA 
 (0.1 miles away)
225-767-0847
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Siva Sankar-Yadlapati is a Hematologist and an Oncologist practicing medicine in Baton Rouge, Louisiana. Dr. Sankar-Yadlapati is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Sickle Cell Disease, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Sankar-Yadlapati is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

Hematology Oncology Associates Of Baton Rouge

4950 Essen Ln, 
Baton Rouge, LA 
 (0.1 miles away)
225-767-1311
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bryan Bienvenu is a Hematologist practicing medicine in Baton Rouge, Louisiana. Dr. Bienvenu is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, and Non-Hodgkin Lymphoma. Dr. Bienvenu is currently accepting new patients.

Expertise in
21
conditions
Dr. Elias Moussaly
Hematology | Oncology
Expertise in
21
conditions
Dr. Elias Moussaly
Hematology | Oncology
Referral may be required

Amedisys Home Health Inc. Of Alabama

5959 S Sherwood Forest Blvd, 
Baton Rouge, LA 
 (3.1 miles away)
337-470-2739
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Elias Moussaly is a Hematologist and an Oncologist practicing medicine in Baton Rouge, Louisiana. Dr. Moussaly is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Cancer. Dr. Moussaly is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew P. Dalovisio

How do I make an appointment with Dr. Andrew P. Dalovisio?

You can book an appointment with Dr. Andrew P. Dalovisio by calling their office at 225-767-0847. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew P. Dalovisio a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew P. Dalovisio is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew P. Dalovisio specialize in?

While Dr. Andrew P. Dalovisio is a Hematology, they have specific expertise in Multiple Myeloma, Acute Myeloid Leukemia (AML), and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Andrew P. Dalovisio participate in research or clinical trials?

Yes. Dr. Andrew P. Dalovisio has published 6 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Andrew P. Dalovisio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew P. Dalovisio accept my insurance?

Dr. Andrew P. Dalovisio accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 225-767-0847 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dalovisio's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 57 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile